ABSTRACT

Significance Chronic wounds (CWs) are a major healthcare challenge, characterized by persistent inflammation that fails to resolve naturally. We found that dysregulation of the proresolving POMC–MC1R pathway is a common feature across different types of CWs including diabetic ulcers and pressure sores. Using a mouse model that replicates human CWs, we demonstrated that targeting MC1R with a topical drug promotes healing by improving blood vessel formation, reducing neutrophil recruitment and NET formation to restore tissue repair. By identifying MC1R as a central regulator of wound repair, we provide a promising therapeutic strategy that could benefit millions of patients suffering from nonhealing wounds.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-47 of 47 references · Page 1 of 1

CITED BY